baber/WOPTO huggingface dataset:
Patent BR-122021014851-B1 (BR)
Title: Aparelho de galvanoplastia
Inventor: MASANARI KIMOTO
IPC: C25D21/10
Filed: 2017-03-02
Abstract: É fornecido um aparelho de galvanoplastia que minimiza as regiões não revestidas quando uma camada de revestimento de liga é proporcionada sobre a superfície de uma rosca em um tubo de aço. Um aparelho de galvanoplastia (10) inclui um eletrodo (1), elementos de vedação (2, 3) e uma unidade de fornecimento de solução de revestimento (4). O eletrodo (1) está voltado para a rosca (Tm). O elemento de vedação (2) é posicionado dentro do tubo de aço (P1). O elemento de vedação (3) é preso à porção de extremidade do tubo de aço (P1) e, juntamente com o elemento de vedação (2), forma um espaço de recebimento (8). A unidade de fornecimento de solução de revestimento (4) inclui uma pluralidade de bocais (42). Os bocais (42) estão posicionados dentro do espaço de recebimento (8) e adjacentes a uma extremidade da rosca (Tm) e dispostos em torno do eixo do tubo do tubo de aço (P1). A unidade de fornecimento de solução de revestimento (4) injeta uma solução de revestimento entre a rosca (Tm) e o eletrodo (1) através dos bocais (42). A direção na qual a solução de revestimento é injetada a partir dos bocais (42) é inclinada em um ângulo maior que 20 graus e menor que 90 graus em direção à rosca (Tm) em relação a um plano (...).
Patent CS-249534-B2 (CS)
Title: Method of cyclohexylurea's sulphonyled derivatives production
Inventor: DAHLOSTROEM MIKAEL U J
IPC: C07C311/59
Filed: 1985-01-16
Abstract: The present invention relates to a method of preparing N-{4-[2-(5-methyl-pyrazinyl-2-carboxamido)-ethyl)-benzenesulphonyl}-N'-cyclohexylurea or glipizide, which has the chemical structure (I),
     by letting 4-[2-(5-methylpyrazinyl)-2-carboxamido)-ethyl]-benzenesulphonamide with the chemical structure (II), where R 1  = NH 2 , react with N-cyclohexyl trichloroacetamide with the chemical structure (III), where R 2  = NHCOCCl 3 , according to the following reaction scheme:
           The reaction is carried out in the presence of a polar, aprotic solvent such as N-methylpyrrolidone (NMP), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA) or dimethylsulphoxide (DMSO) under anhydrous conditions in the presence of a base such as an alcoholate, amide or hydride of an alkali metal. The reaction mixture is heated under reflux condensation to 40-100°C and the reaction is going on for 2-5 hours.
Patent CS-268836-B2 (CS)
Title: Fungicide and method of its effective substances production
Inventor: SAUTER HUBERT DR
IPC: C07C215/02
Filed: 1987-09-03
Abstract: 1. A trans-4-substituted cyclohexylamine derivative of the formula   see diagramm : EP0258853,P24,F2   where R**1 is the group CR**5 R**6 R**7 , in which R**5 , R**6 and R**7 are identical or different and are each hydrogen, branched or straight-chain, unsubstituted or hydroxyl-substituted C1 -C8 -alkyl, C1 -C6 -alkoxy, C1 -C6 -alkylthio or C3 -C6 -cycloalkyl, with the proviso that not more that one of the substituents R**5 , R**6 and R**7 may be hydrogen, or in which R**5 has one of the above meanings and R**6 and R**7 together with the included carbon atom form a three-membered to six-membered carbocyclic aliphatic ring, R**2 and R**3 are identical or different and are each hydrogen, C1 -C20 -alkyl, C2 -C4 -alkenyl or C3 - or C4 -alkynyl or C3 -C12 -cycloalkyl or C5 -C8 -cycloalkenyl, which in turn may be substituted by hydroxyl, C1 -C8 -alkoxy, C1 -C6 -alkylthio, C1 -C8 -alkyl, C2 -C4 -alkenyl, C3 - or C4 -alkynyl or unsubstituted or substituted C3 -C12 -cycloalkyl or by phenyl, naphthyl, phenoxy or naphthyloxy, which in turn may be unsubstituted or substituted by C1 -C8 -alkyl, C2 -C4 -alkenyl, C3 - or C4 -alkynyl or C3 -C6 -cycloalkyl or C5 -C8 -cycloalkyl, C2 -C8 -alkoxy, halogen or trifluoromethyl, with the proviso that the sum of the carbon atoms and hetero atoms (O, S and halogen) of R**2 and R**3 together is not less than 8, the radicals R**4 are identical or different substituents selected from the group consisting of hydrogen, C1 -C8 -alkyl, C3 -C8 -cycloalkyl and C1 -C8 -alkoxy, and m is 1 to 4, and the ~.~.~. bond is a single or a double bond, or a salt thereof, with the exception of a compound in which at one and the same time R**1 is tert-butyl, one of R**2 and R**3 is hydrogen and the other is unsubstituted C8 -C12 -alkyl, and R**4 is hydrogen.
Patent CS-211365-B2 (CS)
Inventor: CSEH MIKLOS
IPC: C22C38/12
Filed: 1979-11-13
Abstract: Vynález se týká výroby obráběcích nástrojů
odléváním do tvaru, odpovídajícího konečnému
tvaru nástroje a zvětšeného jen o
nezbytný přídavek na broušení.
Nástroje se odlévají z oceli, obsahující v
hmotnostních množství 2 až 6 % chrómu, 0
až 24 °/o wolframu, 0 až 10 % molybdenu, 0,5
až 8,0 % vanadu, 0 až 10 % kobaltu, 0 až 3 %
titanu a běžné příměsi jako mangan, křemík,
fosfor a síru.
Podstata vynálezu spočívá v tom, že hmotnostní
koncentrace uhlíku se nejprve upraví
tak, aby před odléváním ocel obsahovala
pouze 0,2 až 0,4 % uhlíku, načež po- dokončení
tavení nebo v průběhu odlévání se přidávají
vzácné zeminy, zejména cer, a/neho
zirkon a/nebo niob v množství 0,1 až 0,8 %,
zejména 0,2 až 0,3%, a potom se v.povrchové
vrstvě odlitých nástrojů zvýší difúzí obsah
uhlíku na nejméně 0,6 %, zejména na
0,7 %.
Patent CS-215094-B2 (CS)
Title: Method of making the 2,6-dihyfroxymethylpyridin-bis+/-methylcarbamate+/
Inventor: SPRUNG MAGDA
IPC: C07D213/30
Filed: 1976-12-31
Abstract: 2,6-Dihydroxymethylpyridine-bis-(N-methylcarbamate) in the  gamma  2 modification is obtained from 2,6-dihydroxymethylpyridine hydrochloride using methyl isocyanate, the purification being effected by recrystallisation from an alcohol-water mixture and the drying being carried out at 50-100 DEG C. The product thus obtained, which is employed in the therapy of vascular diseases, can easily be made into tablets.
Patent AU-765810-B2 (AU)
Title: Method for obtaining active beta-NGF
Inventor: RUDOLPH RAINER
IPC: C07K14/48
Filed: 1999-10-11
Granted: 2003-10-02
Abstract: Preparation of biologically active beta-NGF comprises denaturing its inactive insoluble proform followed by renaturation and pro-sequence cleavage. Preparation of biologically active  beta -NGF from its inactive insoluble proform, obtained by recombinant preparation in prokaryotic cells comprises: (a) dissolving ProNGF in its inactive insoluble form in a denaturating solution ; (b) transferring into a non- or weak denaturing solution where the denatured proNGF assumes a biologically active conformation, determined by the presence of disulfide bridges occurring in natural beta -NGF; and (c) cleaving the pro-sequence to obtain the active  beta -NGF followed by its isolation.
Patent AU-702544-B2 (AU)
Title: Process for the preparation of organic disulphides and polysulphides in the presence of polystyrene-divinyl- benzene (PS-DVB) resins possessing guanidine or amidine groups
Inventor: ARRETZ EMMANUEL
IPC: B01J31/06
Filed: 1996-12-03
Granted: 1999-02-25
Abstract: In a process for the preparation of organic disulphides and polysulphides by reaction of sulphur with a mercaptan or with a polysulphide of lower sulphur order in order to convert it into polysulphide of higher order, or alternatively by reaction of a mercaptan with an organic polysulphide of a high sulphur order in order to convert it into a polysulphide of lower sulphur order, in the presence of a catalyst in the form of a resin with a basic function, the resin is based on a polystyrene-divinyl benzene support functionalized with guanidine or amidine groups, and the reaction is preferably conducted in the presence of methanol.
Patent AU-699817-B2 (AU)
Title: Process for obtaining insulin, having correctly linked cystine bridges
Inventor: OBERMEIER RAINER
IPC: C07K1/113
Filed: 1995-02-16
Granted: 1998-12-17
Abstract: Claimed is a process for the isolation of correctly linked insulin by reacting (a) a protein of the formula R<2>-R<1>-B2-B29-Y-X-Gly-A2-A20-R<3> (II) in which X = amino acids Lys or Arg or a peptide with 2 to 35 amino acids contg. Arg or Lys at the N-terminal and carboxyl end of the peptide Y = amino acid R<1> = phenyl alanine residue or a covalent bond R<2> = hydrogen, Arg or Lys, a peptide with 2 to 45 amino acids contg. Arg or Lys at the carboxyl end of the peptide, R<3> = an amino acid residue, A2-A20 and B2 to B29 correspond to the amino acid sequence of the A or B chain respectively of human insulin, animal insulin or insulin derivs. with an mercaptan amt. resulting in 2 to 10 SH-residues of the mercaptan per cystein residue of formula (II) in the presence of a chaotropic auxiliary agent in an aq. medium at a pH of 10 to 11 and protein concns. of 0.05 and 0.3 g/l, (b) reacting the proinsulin obtd. including correctly linked cystine bridges with either trypsin, trypsin-like protein or opt. also with carboxypetidase B or a mixt. thereof for the prodn. of correctly folded insulin and (c) adding to the prod. of (b) 3 to 50 g of a hydrophobic absorber resin per litre of aq. medium at a pH of 4 to 7 and (d) isolating the absorber resin with absorbed insulin and e) eluting the insulin.
Patent AU-753211-B2 (AU)
Title: Mechanical transmission device for engine with variable volume displacement
Inventor: RABHI VIANNEY
IPC: F01B31/14
Filed: 1999-11-25
Granted: 2002-10-10
Abstract: A mechanical transmission device for an engine with variable volume displacement comprising a piston (2) interlocked in its lower part with a control rack (3), co-operating with a ball-bearing guiding device (4) and with a gear assembly (5) integral with a connecting rod (6) for transmitting movement between the piston and the connecting rod.
Patent AU-622591-B2 (AU)
Title: Grouting composition comprising slag
Inventor: CLARKE WILLIAM J
IPC: E02D3/12
Filed: 1988-01-13
Granted: 1992-04-09
Abstract: A grouting composition, a method of grouting and a formation so grouted are disclosed. The composition comprises a very small particle size slag, an equal or greater weight of water and the optional components cement, alkali silicate, anionic dispersant, a source of orthophosphate ions, sodium hydroxide and sodium carbonate. The grout is particularly adapted to the treatment of "tight" or low permeability formations being low in viscosity and having controllable set time and hardening time as well as high strength upon hardening. Being based on slag, a byproduct, the grout is economical.
Patent AU-670899-B2 (AU)
Title: Electrical terminal and coupling connector
Inventor: ALBECK BERNHARD
IPC: H01R13/506
Filed: 1995-04-19
Granted: 1996-08-01
Abstract: The clamp has relatively spaced termination points (16) for electrical leads and associated contact devices for connecting the inserted leads, with the clamps housing (1) formed in at least 2 parts (2, 3), each providing at least one of the termination points. The housing parts are combined to form a single unit, with at least one termination point (18) of the latter provided with a knife clamp contact device, to allow automatic wiring. The assembled unit has interlocking elements (51), allowing it to be combined with other similar units providing the same, or a different, function. The knife contact termination point is pref provided at the separation plane between the individual parts of the clamp housing. <IMAGE>
Patent AU-652633-B2 (AU)
Title: Organosiloxanes for use as sunscreen agents
Inventor: FRATER GEORG
IPC: C08G77/38
Filed: 1992-05-07
Granted: 1994-09-01
Abstract: Novel organosiloxane compounds have at least one unit    <IMAGE>  (i)  C6R22H2CHC[C(O)OR3]2  any other units being present in this organosiloxane are l, R1 is H or a C1-5 alkyl, R2 is H, C1-5 alkyl or OR1, R3 is a C1-5 alkyl, R'' is H, a monovalent C1-8 hydrocarbon or halogenated hydrocarbon group, a is 0, 1 or 2, b 0, 1, 2 or 3 and n 1 to 6, provided the -C(R1)=CH-(CR21)n-O- group and the two R2 groups are linked to the aromatic ring at the para- and meta-positions in relation to the group -CH=C[C(O)OR3]2. The compounds are useful as UV sunscreens. Compositions containing them are also included.
Patent AU-780053-B2 (AU)
Title: Novel 1,8-naphthyridin-2(1H)-one derivatives
Inventor: AOTSUKA TOMOJI
IPC: A61P9/04
Filed: 2000-12-07
Granted: 2005-02-24
Abstract: The purpose is to provide selective PDE IV inhibitors which have a potent anti-asthmatic profile with excellent safety. A compound of the formula (1): <CHEM>  wherein:   A is an unsubstituted or optionally substituted 5 or 6 membered heteroaryl group or a fused benzene ring in which any of the above-defined heteroaryl groups is fused to a benzene ring,   B is carbon or nitrogen, R<1> is hydrogen, lower alkyl, trifluoromethyl, hydroxyl, lower alkoxy, a residue derived from a carboxylic acid or a derivative thereof, amino, or an amino nitrogen-containing group, R<2> is hydrogen, halogen, cyano, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, trifluoromethyl, hydroxyl, lower alkoxy, a residue derived from a carboxylic acid or a derivative thereof, amino, or an amino nitrogen-containing group, and   m is an integer of from 1 to 8, both inclusive; or a pharmaceutically acceptable salt thereof possesses selective PDE IV inhibition and is useful as a pharmaceutical drug, preferably an anti-asthmatic, etc.
Patent AU-683538-B2 (AU)
Title: Lamina-shaped borepiece for self-boring fastening elements
Inventor: PALM ERICH
IPC: F16B13/13
Filed: 1995-02-13
Granted: 1997-11-13
Abstract: PCT No. PCT/EP95/00514 Sec. 371 Date Sep. 6, 1996 Sec. 102(e) Date Sep. 6, 1996 PCT Filed Feb. 13, 1995 PCT Pub. No. WO95/24566 PCT Pub. Date Sep. 14, 1995A lamina-shaped borepiece (4) for a self-boring fastening element (1) is provided at its front side with cutting edges (5,6) flanked by grooves (7,8) that extend approximately parallel thereto. Indents (9,10) with set-back cutting edges (11,12) are provided in the area of both front cutting edges (5,6), so that a kind of stepped borer is created. The indents (9,10) are formed in the area of the axial extension of the grooves (7,8).
Patent AU-659170-B2 (AU)
Title: Power plant utilizing compressed air energy storage and saturation
Inventor: COHN ARTHUR
IPC: F02G5/02
Filed: 1992-04-06
Granted: 1995-05-11
Abstract: An improved power plant employing a combination of compressed air storage and saturation (simultaneous heating and humidification) of compressed air is disclosed. The power plant includes a combustor which provides hot gas for driving a turbine. The turbine is used in conjunction with a generator to generate electrical power. The power from the turbine is accessible by a compressor system during low power demand periods. The compressor system is used to compress air which is stored in an air storage chamber. The compressed air from the air storage chamber is used by the combustor during high power demand periods, while the compressor system is shut down, to provide compressed combustion gas to the turbine. To enhance the efficiency of the plant, while further lowering the capital cost of the plant, a saturator is positioned between the storage chamber and the combustor. The saturator receives compressed air from the storage chamber and simultaneously heats and humidifies it. The resultant heated and humidified compressed air is then conveyed to the combustor, typically after further heating by a recuperator.
Patent AU-666857-B2 (AU)
Title: Synthetic pulmonary surfactant peptides
Inventor: COCHRANE CHARLES G
IPC: C07K14/785
Filed: 1992-06-01
Granted: 1996-02-29
Abstract: The present invention discloses useful peptides and synthetic pulmonary surfactants, as well as methods of making and using same. In a preferred embodiment, a synthetic pulmonary surfactant comprises one or more pharmaceutically acceptable phospholipids admixed with a polypeptide comprising at least 10 amino acid residues and no more than about 60 amino acid residues, said polypeptide including a sequence having alternating hydrophobic and hydrophilic amino acid residue regions. In other embodiments, a surfactant peptide has an amino acid residue sequence selected from the group consisting of KLLLLKLLLLKLLLLKLLLLK, KLLLLLLLLKLLLLLLLLKLL, and KKLLLLLLLKKLLLLLLLKKL.
Patent AU-656404-B2 (AU)
Title: Cooling method of continuous casting and its mold
Inventor: OHATAKE NORIO
IPC: B22D11/00
Filed: 1992-09-01
Granted: 1995-02-02
Abstract: A cooling method and a cooling mold in a continuous casting wherein even if a continuous casting rate is increased, a proper cooling is carriedout to prevent a danger of a breakout, so as to improve the stability of casting and the high quality of an ingot (4). A cooling mold comprises water cooling jackets (21, 22) which are provided in the inner part of the mold (2), a first cooling water jetting mouth (23) which is arranged at a distance of 20 to 45 mm between a contact position of a primary cooling water and an other contact position of a secondary cooling water on the ingot (2). By use of the cooling mold (2) wherein a primary and a secondary cooling water impinging angles are respectively set at 15 to 30 degrees and at 30 to 60 degrees, the primary cooling water is impinged from the first cooling water jetting mouth (23) to a molten metal (3) which is cooled with the inner surface of the cooling mold (2) to carry-out a primary cooling, and nextly, the secondary cooling water is impinged from the second cooling water jetting mouth (24) to initial zones of a transition boiling zone and a film boiling zone which are produced with the impingement of the primary cooling water, so that a vapor film generated in the transition boiling zoneand the film boiling zone is broken out to provoke a nucleate boiling so as to carry out a direct se condary cooling with the secondary cooling water. <IMAGE>
Patent AU-686794-B2 (AU)
Title: Angled threaded cable union
Inventor: FEKETITSCH HERBERT
IPC: H02G3/06
Filed: 1995-04-14
Granted: 1998-02-12
Abstract: PCT No. PCT/EP95/01409 Sec. 371 Date Oct. 11, 1996 Sec. 102(e) Date Oct. 11, 1996 PCT Filed Apr. 14, 1995 PCT Pub. No. WO95/28759 PCT Pub. Date Oct. 26, 1995In order to bending stress on an inserted cable in an angular cable gland with two enclosure sections, the bore axes of which intersect, occuring due to a conventional right-angle of intersection, it is suggested to connect the two end section (10 and 14) of the enclosure by an intermediate section (12) of the same in such way that each intermediate section is adjacent to two end sections in an obtuse angle.
Patent AU-562495-B2 (AU)
Title: Pyridine-pyrimidinone derivatives
Inventor: SCHICKANEDER HELMUT
IPC: C07D401/06
Filed: 1983-12-21
Granted: 1987-06-11
Abstract: The invention relates to new pyridine-pyrimidinone derivatives corresponding to the following general formula    <IMAGE>  (I) wherein R1 represents linear C1-6 alkyl or cycloalkyl and R2 represents linear C1-6 alkyl or R1 and R2 together with the nitrogen atom form a pyrrolidine or piperidine ring; Alk represents a linear alkylene chain C1-6; Q represents a benzene ring, furan ring, thiophene ring or thiazole ring; X represents oxygen, Y is a single bond and m is 2, 3 or 4 when Q represents benzene; X represents methylene, Y represents sulfur and m is 2 or 3 when Q is furan, thiophene or thiazole; and R3 represents a hydrogen atom or a lower alkyl group. These compounds show improved H2-antagonistic activity.
Patent AU-782915-B2 (AU)
Title: Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
Inventor: DIARRA MOUSSA S
IPC: A61L2/16
Filed: 2000-12-19
Granted: 2005-09-08
Abstract: The present invention relates to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant microorganisms. Lactoferrin (LF) or Lactoferricin (LFC) can be administrated alone or in combination with antibiotic to affect growth, physiology and morphology of targeted microorganism. Lactoferrin increase susceptibility and can reverse resistance of microorganism to antibiotics.
Patent AU-662349-B2 (AU)
Title: Tamper-evident cap for a container
Inventor: OGDEN BRIAN LESLIE
IPC: B65D55/02
Filed: 1992-07-29
Granted: 1995-08-31
Abstract: A (1) cap for a container having a screw threaded opening comprising an inner part (3) in the form of a screw threaded cap, an outer part (2), the inner part (3) being axially displaceable relative to the outer part (2) and biased therefrom between an unlocking and locking position, resilient biasing means (17) between the inner and outer parts, a boss (6), and engagement means (15) adapted to engage with the boss (6) upon depression of the outer part (2), such that turning the cap will unscrew it from the container, wherein one of the boss (6) or engagement means (15) is located on the top surface of the inner part (3) and the other is located on the inner top surface of the outer part (2). <IMAGE>
Patent AU-620348-B2 (AU)
Title: Rolled-up packaging system and method
Inventor: PHARO DANIEL A
IPC: B65D81/02
Filed: 1988-11-03
Granted: 1992-02-20
Abstract: A packaging system comprises a rolled-up bag (11) generally assuming a spiraled configuration and defining an inflatable chamber therein adapted to be at least partially filled with a filler medium, such as pressurized air. A pouch (13) is secured on the bag for retaining an article (16) within the confines thereof. The bag (11) is adapted to be pre-placed within a closeable box (12) and the article (14) then placed in the pouch (13), or , alternatively, the article 914) can be placed in the bag, (11) the bag rolled-up and then placed in the box (12). The bag is then inflated to at least substantially encapsulate and support the pouch (13) and article (14) within rolled-up portions of the bag (11).
Patent AU-753239-B2 (AU)
Title: Polyolefin film, its use, and process for its production
Inventor: RASP WOLFGANG
IPC: B32B27/32
Filed: 1999-05-24
Granted: 2002-10-10
Abstract: Multilayer, biaxially oriented polyolefin film with a base layer and at least one outer layer, in which the base layer contains a fatty acid amide and outer layer D1 contains at least 80 wt.% of a linear olefin polymer (LOP). Independent claims are also included for: (a) A process for the production of this film by coextrusion of the melts for the different layers through a sheet die, drawing the film over a takeoff roller at 40-100 degrees C, biaxially stretching with ratios of (4:1)-(7:1) in the machine direction and (8:1)-(10:1) in the transverse direction, heat-fixing, optionally subjecting to corona treatment and then winding on a spool; (b) laminates containing this film and a layer of polyethylene.
Patent AU-619812-B2 (AU)
Title: A recombinant marek's disease virus and a vaccine
Inventor: ISHIKAWA TOYOKAZU
IPC: C07K14/165
Filed: 1989-03-17
Granted: 1992-02-06
Abstract: There is provided a recombinant Marek's disease virus comprising the genomic DNA of an attenuated Marek's disease virus and a foreign gene from another source. The present recombinant virus can advantageously be used as an active ingredient for a multifunctional live vaccine, exhibiting not only the antigenicity and immunogenicity of the Marek's disease virus but also the properties ascribed to the foreign gene. Since the suitable host cell for the recombinant virus of the present invention is an avian cell which is available in a large quantity and not expensive, the recombinant virus of the present invention can be produced efficiently at low cost on a commercial scale.
Patent AU-678144-B2 (AU)
Title: ICAMs immunoglobulin constant region soluble fusion proteins
Inventor: ARUFFO ALEJANDRO
IPC: C12N15/09
Filed: 1992-12-15
Granted: 1997-05-22
Abstract: Soluble fusion molecules were prepared which contained a CD11a/CD18 specific binding region operatively linked to an immunoglobulin constant region. These molecules particularly include extracellular portions of adhesion molecules such as ICAM-1 and ICAM-2 attached to IgG constant regions. The fusion molecules described are utilized as costimulatory agents for the activation of T cells and in methods for increasing CD4+ T cell proliferative response and IL-2 induction.